Synaptic Retrogenesis and Amyloid-β in Alzheimer’s Disease
Pages 1-14
Review: Pathological hallmarks of Alzheimer’s disease (AD) include synaptic and neuronal degeneration and the presence of extracellular deposits of amyloid-β (Aβ) in senile plaques in the cerebral cortex. Although these brain lesions may be seen also in aged non-demented individuals, the increase in brain Aβ is believed by many to represent the earliest event in the disease process. Accumulating evidence suggests that Aβ, which is highly conserved by evolution, may have an important physiological role in synapse elimination during brain development. An intriguing idea is that this putative function can become pathogenic if activated in the aging brain. Here, we review the literature on the possible physiological roles of Aβ and its precursor protein AβPP during development with special focus on electrophysiological findings.
Similar entries
- Amyloid-β immunisation for Alzheimer's disease
- Calcium signalling and Amyloid
- A fragment of the scaffolding protein RanBP9 is increased in Alzheimer’s disease brains...
- Amyloid- protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- Alzheimer's: How Amyloid Beta Reduces Plasticity Related to Synaptic Signaling
- Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome
- Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's
- Alzheimer's theory makes a splash
- Genetic association to the amyloid plaque associated protein gene COL25A1 in Alzheimer's disease
- Inflammation may trigger Alzheimer's disease



